Related Subjects:
|Neurofibromatosis Type 1
|Neurofibromatosis Type 2
|Tuberous sclerosis
|CafΓ©-au-lait spots
|McCune Albright syndrome
π About
- Prevalence: NF1 is around 10Γ more common than NF2. Estimated prevalence β 1 in 3,000. π§¬
- Exam Focus: NF1 features are far more likely to appear in exams than NF2 due to its distinctive skin, eye, and tumour manifestations. π
𧬠Aetiology
- Inheritance: Autosomal dominant (50% chance of transmission), but ~50% arise from de novo mutations. πͺ
- Gene: Mutation in NF1 gene on chromosome 17, encoding neurofibromin, a tumour suppressor protein regulating the Ras/MAPK pathway.
- Pathophysiology: Loss of neurofibromin β β Ras activity β uncontrolled cell growth β neurofibroma formation. π¬
π©Ί Clinical Features
- Cutaneous Neurofibromas: Multiple, soft, rubbery nodules under the skin. May cause cosmetic concerns or compress structures.
- Plexiform Neurofibromas: Larger, deeper tumours, can cause disfigurement or functional loss; risk of malignant peripheral nerve sheath tumour (~10%). β οΈ
- Axillary/Inguinal Freckling: βCroweβs signβ β pathognomonic for NF1. π
- CafΓ©-au-lait Spots: β₯6 macules (>5 mm in children, >15 mm in adults). Best seen with Woodβs lamp on pale skin. β
- Lisch Nodules: Iris hamartomas, visible on slit-lamp exam, usually asymptomatic but highly diagnostic. ποΈ
- Optic Gliomas: Can impair vision, often detected in childhood. π
- Bony Abnormalities: Tibial bowing, scoliosis, pseudoarthrosis, macrocephaly, short stature. π¦΄
- Hypertension: May be due to renal artery stenosis or phaeochromocytoma. π©Έ
Lisch Nodules:
π Associated Conditions
- Renal Artery Stenosis: Secondary hypertension, common in children with NF1.
- Phaeochromocytoma: Catecholamine-secreting tumour β paroxysmal hypertension, palpitations, sweats. β‘
- CNS Tumours: Optic glioma (classic), astrocytoma, glioblastoma, ependymoma, meningioma.
- Pulmonary Fibrosis and Cardiomyopathy β rare but reported complications.
- Rare links: Medullary thyroid carcinoma in some NF1 patients, overlap with MEN syndromes is debated. π¦
π οΈ Management
- Monitoring: Annual BP, ophthalmology review (children), dermatology/neurology surveillance for tumour burden.
- Genetic Counselling: Key for affected families (autosomal dominant inheritance, variable penetrance). π¨βπ©βπ§βπ¦
- Multidisciplinary Care: Dermatology, neurology, ophthalmology, genetics, orthopaedics.
- Surgery: Reserved for symptomatic or function-threatening neurofibromas; plexiform lesions can be challenging to excise.
- New Therapies: MEK inhibitors (e.g. selumetinib) show promise in shrinking plexiform neurofibromas. π
π Key Exam Pearls
β
CafΓ©-au-lait spots + axillary freckling + neurofibromas = think NF1.
β
Always check BP in NF1 patients β hypertension may be due to renal artery stenosis or phaeochromocytoma.
β
Lisch nodules are highly specific for NF1, best seen with slit-lamp.
β
NF1 β risk of malignant peripheral nerve sheath tumours β any rapidly enlarging/painful neurofibroma = red flag. π¨
π References
Cases β Neurofibromatosis Type 1 (NF1)
- Case 1 β Child with CafΓ©-au-Lait Spots:
A 7-year-old boy is referred for multiple light-brown skin patches. Exam: β₯6 cafΓ©-au-lait spots >5 mm, axillary freckling, and a soft, pedunculated nodule on the arm (cutaneous neurofibroma). Ophthalmology exam reveals Lisch nodules on the iris.
Diagnosis: NF1 based on NIH diagnostic criteria.
Management: Multidisciplinary follow-up (neurology, dermatology, ophthalmology); annual BP monitoring (risk of renal artery stenosis); genetic counselling.
- Case 2 β Adolescent with Plexiform Neurofibroma:
A 14-year-old girl with known NF1 presents with a large, soft, βbag-of-wormsβ mass along her neck that has been enlarging. Exam: scoliosis and multiple cutaneous neurofibromas. MRI: plexiform neurofibroma extending along the brachial plexus.
Diagnosis: NF1 with plexiform neurofibroma.
Management: Surgical debulking if symptomatic or compressive; regular imaging for malignant transformation risk (MPNST); psychosocial support.
Teaching Commentary π§¬
NF1 is an autosomal dominant neurocutaneous disorder (chromosome 17, neurofibromin gene). Diagnostic features (need β₯2):
- β₯6 cafΓ©-au-lait spots,
- β₯2 neurofibromas or 1 plexiform neurofibroma,
- Axillary/inguinal freckling,
- Optic glioma,
- β₯2 Lisch nodules (iris hamartomas),
- Distinctive bone lesion (sphenoid dysplasia, tibial bowing),
- First-degree relative with NF1.
Complications: learning disability, hypertension (renal artery stenosis, phaeochromocytoma), scoliosis, optic gliomas, malignant peripheral nerve sheath tumours.
Management: lifelong surveillance with multidisciplinary input.